dc.contributor.author | Onlen, Y. | |
dc.contributor.author | Cuvalci, N. O. | |
dc.contributor.author | Sari, N. D. | |
dc.contributor.author | Kurtaran, B. | |
dc.contributor.author | Namiduru, M. | |
dc.contributor.author | Batirel, A. | |
dc.contributor.author | Yamazhan, T. | |
dc.contributor.author | Kaya, S. | |
dc.contributor.author | Ince, N. | |
dc.contributor.author | Tabak, F. | |
dc.contributor.author | Dokmetas, I. | |
dc.contributor.author | Esen, S. | |
dc.date.accessioned | 2021-03-05T19:35:03Z | |
dc.date.available | 2021-03-05T19:35:03Z | |
dc.identifier.citation | Tabak F., Cuvalci N. O. , Kurtaran B., Onlen Y., Sari N. D. , Kaya S., Ince N., Esen S., Dokmetas I., Namiduru M., et al., "Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey", International Liver Congress (ILC), Paris, Fransa, 11 - 15 Nisan 2018, cilt.68 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_cff0eaea-3d0e-46fc-a874-7d23875036e1 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/137489 | |
dc.identifier.uri | https://doi.org/10.1016/s0168-8278(18)30814-6 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey | |
dc.type | Bildiri | |
dc.contributor.department | Antalya Training & Research Hospital , , | |
dc.identifier.volume | 68 | |
dc.contributor.firstauthorID | 153199 | |